✦ LIBER ✦

Angiotensin II does not affect endothelial tone in Type 1 diabetes—results of a double-blind placebo controlled trial

✍ Scribed by D. L. Browne; D. R. Meeking; S. E. Allard; J. L. Munday; K. M. Shaw; M. H. Cummings

Book ID: 110924639
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 125 KB
Volume: 23
Category: Article
ISSN: 0742-3071
DOI: 10.1111/j.1464-5491.2005.01727.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of Metformin in Type II Diabete

Efficacy of Metformin in Type II Diabetes: Results of a Double-Blind, Placebo-controlled, Dose-Response Trial

✍ Alan J. Garber MD; PhD; Theodore G. Duncan MD; Anita M. Goodman MD; Donna J. Mil 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Efficacy of Metformin in Type II Diabete

Efficacy of Metformin in Type II Diabetes: Results of a Double-Blind, Placebo-controlled, Dose-Response Trial

✍ Alan J. Garber MD; PhD; Theodore G. Duncan MD; Anita M. Goodman MD; Donna J. Mil 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Creatine supplementation does not impair

Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial

✍ Bruno Gualano; Vitor de Salles Painelli; Hamilton Roschel; Rebeca Lugaresi; Egid 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 264 KB

Does metformin improve vascular heath in

Does metformin improve vascular heath in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial

✍ Jemma Anderson, Alexia S Peña, Thomas Sullivan, Roger Gent… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 236 KB

Ginseng does not Enhance Psychological W

Ginseng does not Enhance Psychological Well-Being in Healthy, Young Adults: Results of a Double-Blind, Placebo-Controlled, Randomized Clinical Trial

✍ BRADLEY J CARDINAL; HERMANN-J ENGELS 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 610 KB

Interferon-α does not improve outcome at

Interferon-α does not improve outcome at one year in patients with diffuse cutaneous scleroderma: Results of a randomized, double-blind, placebo-controlled trial

✍ Carol M. Black; Alan J. Silman; Ariane I. Herrick; Christopher P. Denton; Helen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

## Objective: To determine whether interferon-alpha (ifnalpha) reduces the severity of skin involvement in early (<3 years) diffuse scleroderma. ## Methods: In a randomized, placebo-controlled, double-blind trial, 35 patients with early scleroderma received subcutaneous injections of either ifnal